Lucia Bio is developing highly selective spleen tyrosine kinase (Syk) inhibitors for potential application in peripheral immunology, neurology and haematology oncology. A collaboration between the University of Queensland Emory Drug Discovery Initiative (QEDDI) and Molecule to Medicine (MTM), Lucia Bio is capitalising on QEDDI’s focused discovery and development of oral small molecule inhibitors of Syk, built on the deep knowledge of Syk and dependent pathways.
| Employees | 2 (0 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
Looking for a particular Lucia Bio employee's phone or email?
Lucia Bio Questions
Lucia Bio is based in Brisbane, Queensland.
G2Crowd Trusted
300K+
Plugin Users
